[HTML][HTML] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-Related …, 2011 - erc.bioscientifica.com
131 I is given in differentiated thyroid cancer (DTC) without taking into account thyroglobulin
(Tg) levels at the time of ablation, whereas 6–18 months later it is a major criterion for cure …
(Tg) levels at the time of ablation, whereas 6–18 months later it is a major criterion for cure …
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-related …, 2011 - pubmed.ncbi.nlm.nih.gov
(131) I is given in differentiated thyroid cancer (DTC) without taking into account
thyroglobulin (Tg) levels at the time of ablation, whereas 6-18 months later it is a major …
thyroglobulin (Tg) levels at the time of ablation, whereas 6-18 months later it is a major …
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-related …, 2011 - europepmc.org
(131) I is given in differentiated thyroid cancer (DTC) without taking into account
thyroglobulin (Tg) levels at the time of ablation, whereas 6-18 months later it is a major …
thyroglobulin (Tg) levels at the time of ablation, whereas 6-18 months later it is a major …
[PDF][PDF] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-Related …, 2011 - scholar.archive.org
Abstract 131I is given in differentiated thyroid cancer (DTC) without taking into account
thyroglobulin (Tg) levels at the time of ablation, whereas 6–18 months later it is a major …
thyroglobulin (Tg) levels at the time of ablation, whereas 6–18 months later it is a major …
[PDF][PDF] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-Related …, 2011 - researchgate.net
Abstract 131I is given in differentiated thyroid cancer (DTC) without taking into account
thyroglobulin (Tg) levels at the time of ablation, whereas 6–18 months later it is a major …
thyroglobulin (Tg) levels at the time of ablation, whereas 6–18 months later it is a major …
[PDF][PDF] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-Related …, 2011 - Citeseer
Abstract 131I is given in differentiated thyroid cancer (DTC) without taking into account
thyroglobulin (Tg) levels at the time of ablation, whereas 6–18 months later it is a major …
thyroglobulin (Tg) levels at the time of ablation, whereas 6–18 months later it is a major …